154 related articles for article (PubMed ID: 25961323)
1. A Note of Caution on the Role of Halogen Bonds for Protein Kinase/Inhibitor Recognition Suggested by High- And Low-Salt CK2α Complex Structures.
Guerra B; Bischoff N; Bdzhola VG; Yarmoluk SM; Issinger OG; Golub AG; Niefind K
ACS Chem Biol; 2015 Jul; 10(7):1654-60. PubMed ID: 25961323
[TBL] [Abstract][Full Text] [Related]
2. Low-density crystal packing of human protein kinase CK2 catalytic subunit in complex with resorufin or other ligands: a tool to study the unique hinge-region plasticity of the enzyme without packing bias.
Klopffleisch K; Issinger OG; Niefind K
Acta Crystallogr D Biol Crystallogr; 2012 Aug; 68(Pt 8):883-92. PubMed ID: 22868753
[TBL] [Abstract][Full Text] [Related]
3. Molecular Plasticity of Crystalline CK2α' Leads to KN2, a Bivalent Inhibitor of Protein Kinase CK2 with Extraordinary Selectivity.
Lindenblatt D; Applegate V; Nickelsen A; Klußmann M; Neundorf I; Götz C; Jose J; Niefind K
J Med Chem; 2022 Jan; 65(2):1302-1312. PubMed ID: 34323071
[TBL] [Abstract][Full Text] [Related]
4. Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design.
Niefind K; Issinger OG
Biochim Biophys Acta; 2010 Mar; 1804(3):484-92. PubMed ID: 19796713
[TBL] [Abstract][Full Text] [Related]
5. Unexpected CK2β-antagonistic functionality of bisubstrate inhibitors targeting protein kinase CK2.
Pietsch M; Viht K; Schnitzler A; Ekambaram R; Steinkrüger M; Enkvist E; Nienberg C; Nickelsen A; Lauwers M; Jose J; Uri A; Niefind K
Bioorg Chem; 2020 Mar; 96():103608. PubMed ID: 32058103
[TBL] [Abstract][Full Text] [Related]
6. A novel class of selective CK2 inhibitors targeting its open hinge conformation.
Dalle Vedove A; Zonta F; Zanforlin E; Demitri N; Ribaudo G; Cazzanelli G; Ongaro A; Sarno S; Zagotto G; Battistutta R; Ruzzene M; Lolli G
Eur J Med Chem; 2020 Jun; 195():112267. PubMed ID: 32283296
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.
Battistutta R
Cell Mol Life Sci; 2009 Jun; 66(11-12):1868-89. PubMed ID: 19387547
[TBL] [Abstract][Full Text] [Related]
8. Enzymatic activity with an incomplete catalytic spine: insights from a comparative structural analysis of human CK2α and its paralogous isoform CK2α'.
Bischoff N; Raaf J; Olsen B; Bretner M; Issinger OG; Niefind K
Mol Cell Biochem; 2011 Oct; 356(1-2):57-65. PubMed ID: 21739153
[TBL] [Abstract][Full Text] [Related]
9. First inactive conformation of CK2 alpha, the catalytic subunit of protein kinase CK2.
Raaf J; Issinger OG; Niefind K
J Mol Biol; 2009 Mar; 386(5):1212-21. PubMed ID: 19361447
[TBL] [Abstract][Full Text] [Related]
10. Structural insight into human CK2alpha in complex with the potent inhibitor ellagic acid.
Sekiguchi Y; Nakaniwa T; Kinoshita T; Nakanishi I; Kitaura K; Hirasawa A; Tsujimoto G; Tada T
Bioorg Med Chem Lett; 2009 Jun; 19(11):2920-3. PubMed ID: 19414254
[TBL] [Abstract][Full Text] [Related]
11. The CK2 alpha/CK2 beta interface of human protein kinase CK2 harbors a binding pocket for small molecules.
Raaf J; Brunstein E; Issinger OG; Niefind K
Chem Biol; 2008 Feb; 15(2):111-7. PubMed ID: 18291315
[TBL] [Abstract][Full Text] [Related]
12. Conformational dynamics of human protein kinase CK2α and its effect on function and inhibition.
Srivastava A; Hirota T; Irle S; Tama F
Proteins; 2018 Mar; 86(3):344-353. PubMed ID: 29243286
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for the design of bisubstrate inhibitors of protein kinase CK2 provided by complex structures with the substrate-competitive inhibitor heparin.
Schnitzler A; Niefind K
Eur J Med Chem; 2021 Mar; 214():113223. PubMed ID: 33571828
[TBL] [Abstract][Full Text] [Related]
14. The catalytic subunit of human protein kinase CK2 structurally deviates from its maize homologue in complex with the nucleotide competitive inhibitor emodin.
Raaf J; Klopffleisch K; Issinger OG; Niefind K
J Mol Biol; 2008 Mar; 377(1):1-8. PubMed ID: 18242640
[TBL] [Abstract][Full Text] [Related]
15. An overview about the impact of hinge region towards the anticancer binding affinity of the Ck2 ligands: a quantum chemical analysis.
Deepa P; Thirumeignanam D; Kolandaivel P
J Biomol Struct Dyn; 2019 Sep; 37(15):3859-3876. PubMed ID: 30301411
[TBL] [Abstract][Full Text] [Related]
16. Discovery of holoenzyme-disrupting chemicals as substrate-selective CK2 inhibitors.
Kufareva I; Bestgen B; Brear P; Prudent R; Laudet B; Moucadel V; Ettaoussi M; Sautel CF; Krimm I; Engel M; Filhol O; Borgne ML; Lomberget T; Cochet C; Abagyan R
Sci Rep; 2019 Nov; 9(1):15893. PubMed ID: 31685885
[TBL] [Abstract][Full Text] [Related]
17. Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate.
Yde CW; Ermakova I; Issinger OG; Niefind K
J Mol Biol; 2005 Mar; 347(2):399-414. PubMed ID: 15740749
[TBL] [Abstract][Full Text] [Related]
18. Structural and Mechanistic Basis of the Inhibitory Potency of Selected 2-Aminothiazole Compounds on Protein Kinase CK2.
Lindenblatt D; Nickelsen A; Applegate VM; Jose J; Niefind K
J Med Chem; 2020 Jul; 63(14):7766-7772. PubMed ID: 32589844
[TBL] [Abstract][Full Text] [Related]
19. Structural and functional analysis of the flexible regions of the catalytic α-subunit of protein kinase CK2.
Papinutto E; Ranchio A; Lolli G; Pinna LA; Battistutta R
J Struct Biol; 2012 Feb; 177(2):382-91. PubMed ID: 22186626
[TBL] [Abstract][Full Text] [Related]
20. Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.
Leung KK; Shilton BH
Biochemistry; 2015 Jan; 54(1):47-59. PubMed ID: 25379648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
